Global Tuberculosis Control 2010 - Florida Department of Health

his section examines the latest data on implementation
of the Stop TB Strategy, and compares progress
with the targets included in the Global Plan to Stop TB,
2011–2015 where applicable. The first three topics covered
are case notifications, treatment success rates for
sputum smear-positive TB patients and case detection
rates for all forms of TB. These all illustrate progress in
implementing DOTS – the foundation of the Stop TB
Strategy. The fourth topic is the engagement of the full
range of care providers in TB control (component 4 of
the strategy) through PPM. Such engagement is essential
to ensure high levels of case detection and treatment
success. The next two sections cover collaborative TB/
HIV activities and the diagnosis and treatment of drugresistant
TB, both of which fall under component 2 of
the Stop TB Strategy.
Boxes are used to feature four topics – laboratory
strengthening, HRD, strengthened surveillance and
rational use of anti-TB medicines. All four topics are
closely related to health-system strengthening (component
3 of the Stop TB Strategy) as well as DOTS and the
engagement of all care providers. ACSM, community TB
care and research (components 5 and 6 of the strategy)
are not discussed because there are limitations in the
available data. In future, additional efforts to compile
better data on these topics will be needed. The data that
are currently available as well as data for all other topics
covered in the 2010 data collection form can be viewed
and downloaded on the WHO web site (www.who.int/tb/
data).
In 2009, 5.8 million cases of TB (new cases and relapse
cases) were notified to NTPs, including 2.6 million new
cases of sputum smear-positive pulmonary TB, 2.0 million
new cases of sputum smear-negative pulmonary TB
(including cases for which smear status was unknown),
0.9 million new cases of extrapulmonary TB and 0.3 million
relapse cases (). 1
Among pulmonary cases, 57% of global notifications
were sputum smear-positive. Among the 22 HBCs, the
percentage of notified cases of pulmonary TB that were
sputum smear-positive was relatively low in Zimbabwe
(29%), the Russian Federation (31%), Pakistan (42%),
1
No distinction is made between DOTS and non-DOTS programmes. This is because by 2007, virtually all (more than 99%) notified cases were
reported to WHO as treated in DOTS programmes. Since 2009, the WHO data collection form has made no distinction between notifications
in DOTS and non-DOTS programmes.